NWBO
NORTHWEST BIOTHERAPEUTICS INCCompany Information
- Company Name
- NORTHWEST BIOTHERAPEUTICS INC
- CIK
- CIK0001072379
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NWBO: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- NWBO
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2023-11-17
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 445,000
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 135,994
- Shares outstanding
- 1,456,663,000
- Ownership
- 0.01%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -10.53%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 2 | 3 | 5 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current | - | - | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 3 | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 5 | 5 | 4 | 8 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 16 | 17 | 17 | 17 | 17 | 16 | 16 | 17 | 17 | 17 | 17 | 17 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | ||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 52 | 52 | 53 | - | - | - | 1 | - | - | - | - | - | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Noncurrent | 73 | 74 | 76 | 23 | 23 | 23 | 23 | 24 | 23 | 24 | 24 | 23 | ||||||
| Assets | 76 | 80 | 81 | 31 | 30 | 28 | 27 | 29 | 28 | 29 | 28 | 31 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 33 | 32 | 31 | 27 | 24 | 21 | 17 | 18 | 15 | 15 | 10 | 12 | ||||||
| Notes Payable Current | 10 | 12 | 9 | 14 | 16 | 20 | 14 | 8 | 9 | 12 | 4 | 8 | ||||||
| Business Combination Contingent Consideration Liability Current | - | - | 9 | 10 | 9 | 9 | 10 | 9 | 8 | 9 | 9 | 9 | ||||||
| Derivative Liabilities Current | - | - | - | - | 1 | 1 | 2 | - | - | 1 | 1 | 1 | ||||||
| Deferred Compensation Share Based Arrangements Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | 7 | 7 | 8 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 73 | 83 | 92 | 88 | 84 | 83 | 68 | 60 | 56 | 62 | 45 | 49 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Notes Payable | 12 | 7 | 12 | 7 | 9 | 7 | 12 | 21 | 20 | 10 | 20 | 11 | ||||||
| Operating Lease Liability Noncurrent | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | ||||||
| Deferred Income Tax Liabilities Net | 13 | 13 | 13 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 37 | 35 | 37 | 38 | 32 | 29 | 37 | 34 | 30 | 20 | 30 | 20 | ||||||
| Liabilities | 111 | 118 | 129 | 126 | 116 | 112 | 106 | 94 | 86 | 82 | 75 | 69 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 19 | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | - | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital Common Stock | 1,469 | 1,455 | 1,443 | 1,396 | 1,378 | 1,361 | 1,345 | 1,334 | 1,316 | 1,301 | 1,291 | 1,271 | ||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -1,516 | -1,507 | -1,504 | -1,505 | -1,478 | -1,463 | -1,443 | -1,415 | -1,396 | -1,378 | -1,360 | -1,341 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -1 | -1 | -2 | 1 | 3 | -0 | 2 | 2 | 2 | 3 | ||||||
| Stockholders Equity | -45 | -51 | -60 | -109 | -100 | -99 | -94 | -80 | -76 | -73 | -66 | -70 | ||||||
| Liabilities And Stockholders Equity | 76 | 80 | 81 | 31 | 30 | 28 | 27 | 29 | 28 | 29 | 28 | 31 | ||||||
| Series C Convertible Preferred Stock | 0 | 10 | 10 | 9 | -0 | 1 | 10 | -0 | -0 | 1 | 10 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,600 | 2,600 | 1,700 | 1,700 | 1,700 | 1,700 | 2,600 | 1,700 | 1,700 | 1,700 | 1,700 | 1,700 | ||||||
| Common Stock Shares Issued | 1,681 | 1,619 | 1,567 | 1,518 | 1,459 | 1,391 | 1,329 | 1,286 | 1,230 | 1,195 | 1,176 | 1,145 | ||||||
| Shares Outstanding | 1,669 | 1,607 | 1,555 | 1,518 | 1,459 | 1,391 | 1,329 | 1,286 | 1,230 | 1,195 | 1,176 | 1,145 | ||||||
| Treasury Stock Common Shares | 12 | 12 | 12 | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNORTHWEST BIOTHERAPEUTICS INC (NWBO) — SEC Financial Statements & Analysis
NORTHWEST BIOTHERAPEUTICS INC (NWBO) is a pharmaceutical preparations company, incorporated in DE. NORTHWEST BIOTHERAPEUTICS INC trades on OTC as: NWBO. NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, NORTHWEST BIOTHERAPEUTICS INC carries a market cap of $312.06M, a P/E ratio of -8.27x, a P/B ratio of -6.91x, a P/S ratio of 143.61x, an enterprise value of $333.95M, and an EV/EBITDA multiple of -7.02x. On profitability, it posts a gross margin of 529.04%, an operating margin of -2316.11%, a net margin of -1736.36%, a Return on Equity (ROE) of 51.84%, and a Return on Assets (ROA) of -71.54%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 98.63% year-over-year, net income growth of -54.39% year-over-year, and EPS growth of -60.06% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.01x, working capital of $-70.78M, a debt-to-equity ratio of -2.45x, a debt ratio of 1.46, an interest coverage ratio of -5.34x, free cash flow of $-49.77M (TTM), and net debt of $21.89M. Figures sourced from SEC EDGAR.
- Market Cap
- $312.06M
- P/E TTM
- -8.27x
- EPS TTM
- $-0.02
- P/B TTM
- -6.91x
- ROE TTM
- 51.84%
- ROA TTM
- -71.54%
- Debt To Equity
- -2.45x
- Free Cash Flow TTM
- $-49.77M
- Net Revenue TTM Growth 1Y
- 98.63%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NORTHWEST BIOTHERAPEUTICS INC in?
NORTHWEST BIOTHERAPEUTICS INC (NWBO) operates in the Pharmaceutical Preparations industry.
What exchange does NWBO trade on?
NORTHWEST BIOTHERAPEUTICS INC (NWBO) trades on the OTC.
Where is NORTHWEST BIOTHERAPEUTICS INC incorporated?
NORTHWEST BIOTHERAPEUTICS INC is incorporated in DE.
When was NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s most recent SEC filing?
NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is NWBO's market cap?
NORTHWEST BIOTHERAPEUTICS INC (NWBO) has a market capitalization of $312.06M as of 2026-06-30.
What is NWBO's EPS (earnings per share)?
NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.
What is NWBO's ROE (return on equity)?
NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s trailing twelve month Return on Equity (ROE) is 51.84% as of 2026-06-30.
What is NWBO's ROA (return on assets)?
NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s trailing twelve month Return on Assets (ROA) is -71.54% as of 2026-06-30.
What is NWBO's EV/EBITDA?
NORTHWEST BIOTHERAPEUTICS INC (NWBO)'s trailing twelve month EV/EBITDA is -7.02x as of 2026-06-30.